Jenkem Technology Co., Ltd. (SHA:688356)

Market Cap	5.37B -0.2%
Revenue (ttm)	373.55M +63.7%
Net Income	42.57M +77.7%
EPS	0.72 +84.0%
Shares Out	60.50M
PE Ratio	123.15
Forward PE	n/a
Dividend	0.31 (0.35%)
Ex-Dividend Date	Jun 29, 2026

Volume	6,804,101
Open	90.30
Previous Close	87.47
Day's Range	87.77 - 102.38
52-Week Range	62.13 - 138.80
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Jenkem Technology

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG pr...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 305
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688356

Financial Performance

In 2025, Jenkem Technology's revenue was 318.22 million, an increase of 40.13% compared to the previous year's 227.10 million. Earnings were 61.70 million, an increase of 106.78%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error